Ten-year predicted coronary heart disease risk in HIV-infected men and women

Robert C Kaplan1, Lawrence A Kingsley, A Richey Sharrett

  • 1Department of Epidemiology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. rkaplan@aecom.yu.edu

Insights

Highly active antiretroviral therapy (HAART) may impact coronary heart disease (CHD) risk in HIV patients. Overweight individuals and those with low income face higher CHD risk, necessitating targeted screening.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Highly active antiretroviral therapy (HAART) is a standard treatment for human immunodeficiency virus (HIV).
  • Traditional vascular risk factors are known contributors to coronary heart disease (CHD).
  • The combined impact of HAART and traditional risk factors on CHD risk in HIV-infected individuals requires further investigation.

Purpose of the Study:

  • To estimate the predicted risk of coronary heart disease (CHD) in HIV-infected and HIV-uninfected adults.
  • To identify factors associated with increased CHD risk among HIV-infected individuals.
  • To assess the association between HAART regimens and CHD risk.

Main Methods:

  • A cohort of HIV-infected and HIV-uninfected adults (men and women) was studied.
  • Predicted CHD risk was calculated using established risk factors: age, sex, lipid levels, blood pressure, diabetes, and smoking status.
  • Associations between HAART use (including specific regimens), body mass index (BMI), income level, and CHD risk were analyzed.

Main Results:

  • A significant proportion of HIV-infected men (17%) and women (12%) had high predicted CHD risk.
  • Compared to protease inhibitor-based HAART, HAART-naive individuals had significantly lower odds of moderate-to-high CHD risk (OR, 0.57).
  • Elevated BMI and low income (<$10,000 annually) were independently associated with increased predicted CHD risk.

Conclusions:

  • In HIV-infected adults, overweight status and low income are significant predictors of increased CHD risk, independent of antiretroviral drug exposure.
  • These findings highlight the need for targeted vascular risk factor screening in HIV-infected individuals with these characteristics.
  • Further research may explore the mechanisms linking HAART, metabolic changes, and cardiovascular outcomes in HIV.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...